Menu Search
Equities

Helix BioPharma Corp

HBP:TOR

Helix BioPharma Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.75
  • Today's Change-0.05 / -6.25%
  • Shares traded7.76k
  • 1 Year change-31.82%
  • Beta-0.8511
Data delayed at least 15 minutes, as of Nov 08 2024 20:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CADView more

In 2024, Helix BioPharma Corp increased its cash reserves by 33.79%, or 273.00k. Cash Flow from Financing totalled 5.51m or -- of revenues. In addition the company used 5.22m for operations while cash used for investing totalled 14.00k.
Cash flow per share-0.2064
Price/Cash flow per share--
Book value per share-0.0018
Tangible book value per share-0.0018
More ▼

Balance sheet in CADView more

Helix BioPharma Corp uses little or no debt in its capital structure.
Current ratio0.9221
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.